Are Some Arthritis Patients Unsuitable Candidates For Biologic Drugs?
Are Some Arthritis Patients Unsuitable Candidates For Biologic Drugs? Wednesday March 29, 2006The newest treatments for rheumatoid arthritis include the biologic drugs: • Enbrel (etanercept) • Remicade (infliximab) • Humira (adalimumab) • Orencia (abatacept) • Rituxan (rituximab) However, some patients are not considered suitable candidates for biologic drugs. Is there ever a point when their medical history doesn’t preclude them from trying the biologics? If it is the case that some people remain unsuitable candidates